A fundamental challenge in preclinical research is accurately predicting human responses using conventional animal models. Traditional approaches often fail to adequately model human disease, creating ...
The oncology-based in-vivo CRO market is witnessing robust growth, driven by the increasing global burden of cancer and the rising demand for preclinical oncology research. Pharmaceutical and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results